Voya Investment Management LLC Reduces Stock Position in Astera Labs, Inc. $ALAB

Voya Investment Management LLC reduced its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 48.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 329,360 shares of the company’s stock after selling 303,595 shares during the quarter. Voya Investment Management LLC owned 0.20% of Astera Labs worth $64,489,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in ALAB. Oliver Lagore Vanvalin Investment Group bought a new stake in Astera Labs in the second quarter valued at about $29,000. Grove Bank & Trust bought a new stake in shares of Astera Labs in the 3rd quarter valued at approximately $68,000. Bernard Wealth Management Corp. acquired a new stake in shares of Astera Labs during the 2nd quarter valued at approximately $36,000. Clearstead Trust LLC lifted its stake in Astera Labs by 46,100.0% during the second quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock worth $42,000 after purchasing an additional 461 shares during the last quarter. Finally, Advisors Asset Management Inc. boosted its holdings in Astera Labs by 68.6% in the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock worth $43,000 after purchasing an additional 194 shares during the period. Institutional investors own 60.47% of the company’s stock.

Astera Labs Trading Up 12.7%

NASDAQ ALAB opened at $164.40 on Friday. The company has a market capitalization of $27.77 billion, a PE ratio of 148.11, a price-to-earnings-growth ratio of 2.72 and a beta of 1.51. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90. The firm’s fifty day simple moving average is $159.73 and its 200-day simple moving average is $155.06.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.10. The business had revenue of $230.58 million during the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. Astera Labs’s quarterly revenue was up 103.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Wall Street Analyst Weigh In

ALAB has been the subject of several analyst reports. Wall Street Zen downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a report on Tuesday, November 11th. Needham & Company LLC upped their target price on shares of Astera Labs from $205.00 to $220.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Citigroup restated an “outperform” rating on shares of Astera Labs in a research note on Tuesday, December 9th. TD Cowen reduced their price objective on Astera Labs from $225.00 to $170.00 and set a “hold” rating for the company in a research report on Wednesday, November 5th. Finally, BNP Paribas Exane initiated coverage on Astera Labs in a research report on Thursday, November 20th. They issued an “outperform” rating and a $225.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $188.17.

Insider Buying and Selling at Astera Labs

In related news, CEO Jitendra Mohan sold 90,459 shares of the company’s stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the transaction, the chief executive officer owned 2,080,418 shares in the company, valued at $301,015,680.42. This represents a 4.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Michael Truett Tate sold 11,430 shares of the firm’s stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $1,653,806.70. Following the completion of the sale, the chief financial officer owned 192,297 shares of the company’s stock, valued at $27,823,452.93. The trade was a 5.61% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 586,936 shares of company stock worth $89,331,140 over the last three months. 12.50% of the stock is currently owned by insiders.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.